TELA Bio (TELA) Competitors

TELA Bio logo
$0.69 -0.04 (-5.27%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$0.70 +0.01 (+0.94%)
As of 11/20/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TELA vs. FOCL, APYX, KEQU, STIM, and OWLT

Should you buy TELA Bio stock or one of its competitors? TELA Bio's main competitors and comparable companies include FocalTherics (FOCL), Apyx Medical (APYX), Kewaunee Scientific (KEQU), Neuronetics (STIM), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does TELA Bio compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and TELA Bio (NASDAQ:TELA) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

FocalTherics currently has a consensus price target of $9.67, indicating a potential upside of 270.37%. TELA Bio has a consensus price target of $2.14, indicating a potential upside of 211.24%. Given FocalTherics' higher probable upside, analysts plainly believe FocalTherics is more favorable than TELA Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FocalTherics
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

FocalTherics has a beta of -0.02, suggesting that its stock price is 102% less volatile than the broader market. Comparatively, TELA Bio has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

TELA Bio has a net margin of -53.57% compared to FocalTherics' net margin of -59.77%. FocalTherics' return on equity of -223.32% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
FocalTherics-59.77% -223.32% -41.32%
TELA Bio -53.57%-1,320.81%-60.17%

In the previous week, FocalTherics' average media sentiment score of 0.00 beat TELA Bio's score of -0.30 indicating that FocalTherics is being referred to more favorably in the media.

Company Overall Sentiment
FocalTherics Neutral
TELA Bio Neutral

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by insiders. Comparatively, 1.1% of TELA Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

FocalTherics has higher earnings, but lower revenue than TELA Bio. FocalTherics is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FocalTherics$70.53M1.39-$29.25M-$0.98N/A
TELA Bio$80.28M0.32-$38.83M-$0.74N/A

Summary

FocalTherics beats TELA Bio on 8 of the 14 factors compared between the two stocks.

How does TELA Bio compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and TELA Bio (NASDAQ:TELA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Apyx Medical has a net margin of -14.16% compared to TELA Bio's net margin of -53.57%. Apyx Medical's return on equity of -68.79% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-14.16% -68.79% -13.36%
TELA Bio -53.57%-1,320.81%-60.17%

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by company insiders. Comparatively, 1.1% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Apyx Medical had 1 more articles in the media than TELA Bio. MarketBeat recorded 1 mentions for Apyx Medical and 0 mentions for TELA Bio. Apyx Medical's average media sentiment score of 1.38 beat TELA Bio's score of -0.30 indicating that Apyx Medical is being referred to more favorably in the media.

Company Overall Sentiment
Apyx Medical Positive
TELA Bio Neutral

Apyx Medical has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

Apyx Medical presently has a consensus target price of $6.20, indicating a potential upside of 158.33%. TELA Bio has a consensus target price of $2.14, indicating a potential upside of 211.24%. Given TELA Bio's higher probable upside, analysts plainly believe TELA Bio is more favorable than Apyx Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Apyx Medical has higher earnings, but lower revenue than TELA Bio. Apyx Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$52.84M1.91-$11.21M-$0.19N/A
TELA Bio$80.28M0.32-$38.83M-$0.74N/A

Summary

Apyx Medical beats TELA Bio on 12 of the 15 factors compared between the two stocks.

How does TELA Bio compare to Kewaunee Scientific?

TELA Bio (NASDAQ:TELA) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

In the previous week, Kewaunee Scientific had 1 more articles in the media than TELA Bio. MarketBeat recorded 1 mentions for Kewaunee Scientific and 0 mentions for TELA Bio. Kewaunee Scientific's average media sentiment score of 0.00 beat TELA Bio's score of -0.30 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
TELA Bio Neutral
Kewaunee Scientific Neutral

94.4% of TELA Bio shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 1.1% of TELA Bio shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Kewaunee Scientific has a net margin of 2.97% compared to TELA Bio's net margin of -53.57%. Kewaunee Scientific's return on equity of 11.61% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-53.57% -1,320.81% -60.17%
Kewaunee Scientific 2.97%11.61%4.82%

Kewaunee Scientific has higher revenue and earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$80.28M0.32-$38.83M-$0.74N/A
Kewaunee Scientific$282M0.35$9.62M$2.7612.22

TELA Bio presently has a consensus price target of $2.14, indicating a potential upside of 211.24%. Given TELA Bio's stronger consensus rating and higher probable upside, equities analysts plainly believe TELA Bio is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

TELA Bio has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

Summary

Kewaunee Scientific beats TELA Bio on 10 of the 15 factors compared between the two stocks.

How does TELA Bio compare to Neuronetics?

TELA Bio (NASDAQ:TELA) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

In the previous week, Neuronetics had 7 more articles in the media than TELA Bio. MarketBeat recorded 7 mentions for Neuronetics and 0 mentions for TELA Bio. Neuronetics' average media sentiment score of 0.22 beat TELA Bio's score of -0.30 indicating that Neuronetics is being referred to more favorably in the news media.

Company Overall Sentiment
TELA Bio Neutral
Neuronetics Neutral

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 1.1% of TELA Bio shares are owned by insiders. Comparatively, 8.4% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

TELA Bio currently has a consensus target price of $2.14, suggesting a potential upside of 211.24%. Neuronetics has a consensus target price of $5.00, suggesting a potential upside of 300.00%. Given Neuronetics' stronger consensus rating and higher possible upside, analysts clearly believe Neuronetics is more favorable than TELA Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Neuronetics
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.67

Neuronetics has a net margin of -14.45% compared to TELA Bio's net margin of -53.57%. Neuronetics' return on equity of -102.23% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
TELA Bio-53.57% -1,320.81% -60.17%
Neuronetics -14.45%-102.23%-16.83%

TELA Bio has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

TELA Bio has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TELA Bio$80.28M0.32-$38.83M-$0.74N/A
Neuronetics$149.16M0.65-$39M-$0.33N/A

Summary

Neuronetics beats TELA Bio on 12 of the 15 factors compared between the two stocks.

How does TELA Bio compare to Owlet?

Owlet (NYSE:OWLT) and TELA Bio (NASDAQ:TELA) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

In the previous week, Owlet had 9 more articles in the media than TELA Bio. MarketBeat recorded 9 mentions for Owlet and 0 mentions for TELA Bio. Owlet's average media sentiment score of 0.32 beat TELA Bio's score of -0.30 indicating that Owlet is being referred to more favorably in the media.

Company Overall Sentiment
Owlet Neutral
TELA Bio Neutral

Owlet has a beta of 2.17, suggesting that its share price is 117% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

72.6% of Owlet shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 1.1% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Owlet presently has a consensus target price of $12.00, suggesting a potential upside of 306.78%. TELA Bio has a consensus target price of $2.14, suggesting a potential upside of 211.24%. Given Owlet's higher possible upside, equities research analysts plainly believe Owlet is more favorable than TELA Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Owlet has a net margin of -11.11% compared to TELA Bio's net margin of -53.57%. Owlet's return on equity of -53.97% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-11.11% -53.97% -13.77%
TELA Bio -53.57%-1,320.81%-60.17%

TELA Bio has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M0.83-$39.68M-$0.68N/A
TELA Bio$80.28M0.32-$38.83M-$0.74N/A

Summary

Owlet beats TELA Bio on 11 of the 13 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TELA vs. The Competition

MetricTELA BioHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$28.02M$5.99B$7.75B$11.70B
Dividend YieldN/A1.69%2.48%4.66%
P/E Ratio-0.9338.2132.5328.82
Price / Sales0.325.437.905.32
Price / CashN/A23.7921.0521.90
Price / Book-1.034.014.263.50
Net Income-$38.83M$143.06M$3.51B$394.12M
1 Month Performance-36.25%-8.30%-10.58%-12.04%
1 Year Performance-41.15%-4.45%-4.79%-11.42%

TELA Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TELA
TELA Bio
2.9363 of 5 stars
$0.69
-5.3%
$2.14
+211.2%
-35.0%$28.02M$80.28MN/A218
FOCL
FocalTherics
1.7256 of 5 stars
$2.86
-9.8%
$9.67
+238.0%
N/A$107.34M$70.53MN/A230
APYX
Apyx Medical
2.3686 of 5 stars
$2.52
-5.1%
$6.20
+146.5%
-40.6%$105.51M$52.84MN/A205
KEQU
Kewaunee Scientific
0.5739 of 5 stars
$34.22
-4.1%
N/A-10.1%$99.24M$282M12.401,231
STIM
Neuronetics
3.6778 of 5 stars
$1.28
+2.6%
$5.00
+290.0%
-3.8%$99.11M$149.16MN/A658

Related Companies and Tools


This page (NASDAQ:TELA) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners